Ondine Biomedical Stock Return On Asset
| OBI Stock | 10.25 0.50 5.13% |
Ondine Biomedical fundamentals help investors to digest information that contributes to Ondine Biomedical's financial success or failures. It also enables traders to predict the movement of Ondine Stock. The fundamental analysis module provides a way to measure Ondine Biomedical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ondine Biomedical stock.
Ondine | Return On Asset |
Ondine Biomedical Company Return On Asset Analysis
Ondine Biomedical's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Ondine Biomedical Return On Asset | -1.6 |
Most of Ondine Biomedical's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ondine Biomedical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Ondine Total Assets
Total Assets |
|
Based on the latest financial disclosure, Ondine Biomedical has a Return On Asset of -1.5971. This is 81.75% lower than that of the Biotechnology sector and 93.23% lower than that of the Health Care industry. The return on asset for all United Kingdom stocks is notably higher than that of the company.
Ondine Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ondine Biomedical's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ondine Biomedical could also be used in its relative valuation, which is a method of valuing Ondine Biomedical by comparing valuation metrics of similar companies.Ondine Biomedical is currently under evaluation in return on asset category among its peers.
Ondine Fundamentals
| Return On Equity | -6.86 | ||||
| Return On Asset | -1.6 | ||||
| Operating Margin | (9.12) % | ||||
| Current Valuation | 44.84 M | ||||
| Shares Outstanding | 442.06 M | ||||
| Shares Owned By Insiders | 42.86 % | ||||
| Shares Owned By Institutions | 21.61 % | ||||
| Price To Book | 4,430 X | ||||
| Price To Sales | 27.73 X | ||||
| Revenue | 1.2 M | ||||
| Gross Profit | 981 K | ||||
| EBITDA | (13.79 M) | ||||
| Net Income | (14.41 M) | ||||
| Total Debt | 541 K | ||||
| Cash Flow From Operations | (13.65 M) | ||||
| Earnings Per Share | (0.03) X | ||||
| Target Price | 60.0 | ||||
| Beta | 0.14 | ||||
| Market Capitalization | 45.31 M | ||||
| Total Asset | 5.73 M | ||||
| Retained Earnings | (266.33 M) | ||||
| Working Capital | 1.26 M | ||||
| Net Asset | 5.73 M |
About Ondine Biomedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ondine Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ondine Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ondine Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in Ondine Stock
Ondine Biomedical financial ratios help investors to determine whether Ondine Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ondine with respect to the benefits of owning Ondine Biomedical security.